The 2000 Canadian hypertension recommendations: A summary;Résumé des recommendations Canadiennes de l'an 2000 sur l'hypertension

Canadian Journal of Cardiology

Volumn 17, Issue 5, 2001, Pages 535-542

  Campbell, N R C ^a   Carruthers, S G ^a   Wilson, E ^a   Nagpal, S ^a   Chockalingam, A ^a   Squires, T ^a   Levine, M ^a   Zarnke, K ^a   McAlister, F ^a   Abbott, C ^a   Mann, K ^a   Bolli, P ^a   McKay, D ^a   Ens, B ^a   Myers, M ^a   Wilson, T ^a   Honos, G ^a   Burgess, E ^a   Petrella, R ^a   Touyz, R ^a   Lewanczuk, R ^a   Wright, J ^a   Culleton, B ^a   Leenen, F ^a   Rabkin, S ^a   Stone, J ^a   Fodor, G ^a   Hamet, P ^a   Herman, R ^a   Lebel, M ^a   Tobe, S ^a   Feldman, R D ^a   Irvine, J ^a   Eady, A ^a   Campbell, N ^a   Milot, A ^a   Feldman, R ^a   Repchinsky, C ^a   Ruddy, T ^a   Stewart, P ^a   Tremblay, G ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; ISOSORBIDE DINITRATE; LOOP DIURETIC AGENT; MINOXIDIL; NIFEDIPINE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADD ON THERAPY; AMBULATORY MONITORING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CANADA; DIAGNOSTIC VALUE; DIET THERAPY; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG RELEASE; HUMAN; HYPERTENSION; INDIVIDUALIZATION; PHYSICAL ACTIVITY; RISK ASSESSMENT; SHORT SURVEY;

EID: 0034954543     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.18549/PharmPract.2024.1.0000     Document Type: Short Survey

References (7)

1. 1
2. 1
3. 1
4. 1
5. 1
6. 1
7. 1